Earlier this year a survey of the state’s 225+ CRO and CMOs. found that together they employ over 16,000 people and represent almost $2.5 billion dollars of state revenues. This and additional results of the survey were formally issued in a report titled Impact 2020 outlining a strategic report on the current state and future of the biotechnology and life science cluster in Massachusetts. With this statement issued by MassBio on May 5th, the organization began advocating for changes to Massachusetts tax incentive and financing programs to include contract research and manufacturing companies that are currently excluded from the Life Science Initiative and other state programs. To view MassBio news piece on this call to action click here. To view the Impact 2020 report click here.
Support for Conract Research & Manufacturing Critical to Growth in Life Sciences
June 13, 2014